IRCCS Foundation Ca' Granda Ospedale Maggiore Policlinico, Dino Ferrari Center, Neuroscience Section, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
Department of Neurology, Ospedale Santa Chiara, Trento, Italy.
Parkinsonism Relat Disord. 2020 May;74:1-5. doi: 10.1016/j.parkreldis.2020.03.018. Epub 2020 Apr 2.
Mutations in the gene encoding the mitochondrial carrier protein SLC25A46 are known to cause optic atrophy associated with peripheral neuropathy and congenital pontocerebellar hypoplasia. We found novel biallelic SLC25A46 mutations (p.H137R, p.A401Sfs*17) in a patient with Parkinson's disease and optic atrophy. Screening of six unrelated patients with parkinsonism and optic atrophy allowed us to identify two additional mutations (p.A176V, p.K256R) in a second patient. All identified variants are predicted likely pathogenic and affect very conserved protein residues. These findings suggest for the first time a possible link between Parkinson's Disease and SLC25A46 mutations. Replication in additional studies is needed to conclusively prove this link.
已知编码线粒体载体蛋白 SLC25A46 的基因突变与视神经萎缩相关,伴有周围神经病和先天性桥脑小脑发育不良。我们在一名帕金森病合并视神经萎缩患者中发现了新型的 SLC25A46 双等位基因突变(p.H137R,p.A401Sfs*17)。对六名无关联的帕金森病伴视神经萎缩患者进行筛查,使我们在第二名患者中发现了另外两种突变(p.A176V,p.K256R)。所有鉴定的变异均被预测为可能致病性的,且影响非常保守的蛋白残基。这些发现首次提示帕金森病与 SLC25A46 基因突变之间可能存在联系。需要在额外的研究中进行复制,以最终证明这种联系。